Oyster Point Pharma Files for $85 Million IPO

Oyster Point Pharma filed the paperwork for $85 Million IPO on 10/4/19. The Princeton, NJ based company is focused on developing pharmaceutical therapies to treat ocular surface diseases. The company will trade on NASDAQ under the symbol “OYST.”